Top-down proteomics and direct surface sampling of neonatal dried blood spots: Diagnosis of unknown hemoglobin variants

Journal of the American Society for Mass Spectrometry

Volumn 23, Issue 11, 2012, Pages 1921-1930

  Edwards, Rebecca L ^a   Griffiths, Paul ^b   Bunch, Josephine ^a   Cooper, Helen J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CID; Direct surface sampling; Dried blood spots; ETD; Hemoglobin variants; Top down mass spectrometry

Indexed keywords

CID; DRIED BLOOD SPOTS; ETD; SURFACE SAMPLING; TOPDOWN;

BLOOD; DISSOCIATION; MASS SPECTROMETRY; MOLECULAR BIOLOGY;

HEMOGLOBIN;

HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN S;

AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; COLLISIONALLY ACTIVATED DISSOCIATION; COMPUTER PROGRAM; DATA ANALYSIS; DIRECT SURFACE SAMPLING; DRIED BLOOD SPOT TESTING; ELECTRON TRANSPORT; HEMOGLOBIN ANALYSIS; HUMAN; HUMAN CELL; INFANT; MASS SPECTROMETRY; NEWBORN; NEWBORN ASSESSMENT; NEWBORN SCREENING; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEOMICS;

AMINO ACID SEQUENCE; DRIED BLOOD SPOT TESTING; HEMOGLOBINS, ABNORMAL; HUMANS; INFANT, NEWBORN; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PROTEOMICS;

EID: 84868228513     PISSN: 10440305     EISSN: 18791123     Source Type: Journal    
DOI: 10.1007/s13361-012-0477-9     Document Type: Article

References (37)

1. Adachi, K., Zhao, Y., Yamaguchi, T., Surrey, S.: Assembly of γ- with α-globin chains to form human fetal hemoglobin in vitro and in vivo. J. Biochem. 275, 12424-12429 (2000)
2. Trent, R.J.A.: Diagnosis of the hemoglobinopathies. Clin. Biochem. Rev. 27, 27-38 (2006)
3. Giardine, B., van Baal, S., Kaimakis, P., Riemer, C., Miller, W., Samara, M., Kollia, P., Anagnou, N.P., Chui, D.H.K., Wajcman, H., Hardison, R.C., Patrinos, G.P.: HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum. Mutat 28, 1-10 (2007)
4. Ingram, V.M.: Abnormal human hemoglobins. III the chemical difference between normal and sickle hemoglobins. Biochim. Biophys. Acta 36, 402-411 (1959)
5. Embury, S.H.: The clinical pathophysiology of sickle cell disease. Annu. Rev. Med. 37, 361-376 (1986)
6. Scott, R.B.: Health care priority and sickle cell anemia. J. Am. Med. Assoc. 214, 731-734 (1970)
7. Davis, H., Schoendorf, K.C., Gergen, P.J., Moore, R.M.: National trends in the mortality of children with sickle cell disease, 1968 throught 1992. Am. J. Public Health 87, 1317-1322 (1997)
8. Telfer, P., Coen, P., Chakravorty, S., Wilkey, O., Evans, J., Newell, H., Smalling, B., Amos, R., Stephens, A., Rogers, D., Kirkham, F.: Clinical outcomes in children with sickle cell disease living in England: A neonatal cohort in East London. Haematologica 92(7), 905-912 (2007)
9. Black, A.J., Condon, P.I., Gompels, B.M., Green, R.L., Huntsman, R.G., Jenkins, G.C.: Sickle-cell hemoglobin C disease in London. J. Clin. Pathol. 25, 49-55 (1972)
10. River, G.L., Robbins, A.B., Schwartz, S.O.: S-C hemoglobin: A clinical study. Blood 18, 385-416 (1961)
11. Streetly, A., Latinovic, R., Hall, K., Henthorn, J.: Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant hemoglobinopathies in England: Screening results for 2005-2007. J. Clin. Pathol. 62(1), 26-30 (2009)
12. Almeida, A.M., Henthorn, J.S., Davies, S.C.: Neonatal screening for haemoglobinopathies: The results of a 10-year programme in an English Health Region. Br. J. Haematol. 112(1), 32-35 (2001)
13. Ryan, K., Bain, B.J., Worthington, D., James, J., Plews, D., Mason, A., Roper, D., Rees, D.C., De La Salle, B., Streetly, A.: Significant haemoglobinopathies: Guidelines for screening and diagnosis. Br. J. Haematol. 149(1), 35-49 (2010)
14. Old, J.M.: Screening and genetic diagnosis of hemoglobin disorders. Blood Rev. 17(1), 43-53 (2003)
15. Daniel, Y.A., Turner, C, Haynes, R.M., Hunt, B J., Dalton, R.N.: Rapid and specific detection of clinically significant haemoglobinopathies using electrospray mass spectrometry-mass spectrometry. Br. J. Haematol. 130(4), 635-643 (2005)
16. Boemer, F., Cornet, Y., Libioulle, C, Segers, K., Bours, V., Schoos, R.: 3-years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry. Clin. Chim. Acta 412(15/16), 1476-1479 (2011)
17. Williams, J.P., Creese, A.J., Roper, D.R., Green, B.N., Cooper, HJ.: Hot electron capture dissociation distinguishes leucine from isoleucine in a novel hemoglobin variant, Hb askew, β54(D5)Val→Ile. J. Am. Soc. Mass Spectrom. 20(9), 1707-1713 (2009)
18. Daniel, Y.A., Turner, C, Haynes, R.M., Hunt, B.J., Dalton, R.N.: Quantification of hemoglobin A2 by tandem mass spectrometry. Clin. Chem. 53(8), 1448-1454 (2007)
19. Rai, D.K., Griffiths, W.J., Landon, B., Wild, B J., Alvelius, G, Green, B.N.: Accurate mass measurement by electrospray ionisation quadrupole mass spectrometry: Detection of variants differing by G6 Da from normal in human hemoglobin heterozygotes. Anal. Chem. 75(9), 1978-1982 (2003)
20. Wild, B.J., Green, B.N., Cooper, E.K., Lalloz, M.R.A., Erten, S., Stephens, A.D., Layton, D.M.: Rapid identification of hemoglobin varints by electrospray ionization mass spectrometry. Blood Cells Mol Dis. 27, 691-704 (2001)
21. Wild, B.J., Green, B.N., Stephens, A.D.: The potential of electrospray ionization mass spectrometry for the diagnosis of hemoglobin variants found in newborn screening. Blood Cells Mol. Dis. 33, 308-317 (2004)
22. Kelleher, N.L., Lin, H.Y., Valaskovic, G.A., Aaserud, DJ., Fridriksson, E.K., McLafferty, F.W.: Top down versus bottom up protein characterization by tandem high-resolution mass spectrometry. J. Am. Chem. Soc. 121, 806-812 (1999)
23. Reid, G.E., McLuckey, S.A.: 'Top down' protein characterization via tandem mass spectrometry. J. Mass Spectrom. 37(7), 663-675 (2002)
24. Cui, W., Rohrs, H.W., Gross, M.L.: Top-down mass spectrometry: Recent developments, applications and perspectives. Analyst 136, 3854-3864 (2011)
25. Van Berkel, G.J., Kertesz, V., Koeplinger, K.A., Vavrek, M., Kong, A.-N.T.: Liquid microjunction surface sampling probe electrospray mass spectrometry for detection of drugs and metabolites in thin tissue sections. J. Mass Spectrom. 43(4), 500-508 (2008)
26. Edwards, R.L., Creese, A.J., Baumert, M., Griffiths, P., Bunch, J., Cooper, HJ.: Hemoglobin variant analysis via direct surface sampling of dried blood spots coupled with high-resolution mass spectrometry. Anal. Chem. 83(6), 2265-2270 (2011)
27. LeDuc, R.D., Taylor, G.K., Kim, Y.-B., Januszyk, T.E., Bynum, L.H., Sola, J.V., Garavelli, J.S., Kelleher, N.L.: ProSight PTM: An integrated environment for protein identification and characterization by top-down mass spectrometry. Nucleic Acids Res. 32(Suppl 2), W340-W345 (2004)
28. Newborn Blood Spot Screening in the UK-Polices and Standards. (2005)
29. Rahbar, S.: Hemoglobin D Iran: β222 glutamic acid→glutamine (B4). Br. J. Haematol. 24(1), 31-35 (1973)
30. Rochette, J., Barnetson, R., Kiger, L., Kister, J., Littlewood, T.J., Webster, R., Poyart, C, Thein, S.L.: Association of a novel high oxygen-affinity haemoglobin-variant with delta-8 thalassemia. Br. J. Haematol. 86(1), 118-124 (1994)
31. Vandenesch, F., Baklouti, F., Francina, A., Vianeyliaud, C, Bertrand, A., Ledevehat, C, Delauney, J.: Hemoglobin J-Baltimore (β-16 (A13)Gly-Asp) - interference with the assay of HBA1C. Clin. Chim. Acta 168(2), 121-128 (1987)
32. Fucharoen, S., Winichagoon, P.: Thalassemia and abnormal hemoglobin. Int. J. Hematol. 76, 83-89 (2002)
33. Lang, A., Lorkin, P.A.: Genetics of human hemoglobins. Br. Med. Bull. 32(3), 239-245 (1976)
34. Wajcman, H., Prehu, M.O., Prehu, C, Blouquit, Y., Prome, D., Galacteros, F.: Hemoglobin Phnom Penh [α 117Phe(H1)-Ile-α 118Thr(H2)]: Evidence for a hotspot for insertion of residues in the third exon of the α 1-globin gene. Hum. Mutat. S1, S20-S22 (1998)
35. Bakhtiar, R., Wu, Q., Hofstadler, S.A., Smith, R.D.: Charge state specific facile gas-phase cleavage of Asp75-Met76 peptide bond in the α-chain of human apohemoglobin probed by electrospray ionization mass spectrometry. Biol. Mass Spectrom. 23(11), 707-710 (1994)
36. NHS Sickle Cell and Thalassemia Screening Programme: Data Report: 2008/09. Informing Policy and Improving Quality. (2008-2009) 37.
37. Papadea, C, Eckman, J.R., Kuenhert, R.S., Platt, A.F.: Comparison of liquid and dried blood for neonatal hemoglobinopathy screening - laboratory and programmatic issues. Pediatrics 93(3), 427-432 (1994)